(Date:12/6/2009)... Ingelheim today announced results from the RE-COVER(TM) study ... thrombin inhibitor (DTI),(2) compared to dose-adjusted warfarin in ... trial were presented at the 51st American Society ... in the New England Journal of Medicine ... outcome of the trial, six month incidence of ...
(Date:12/4/2009)... National Institute of Standards and Technology (NIST) and the ... introduce magnetic impurities in a semiconductor crystal by prodding ... a recent paper,* this technique will enable researchers to ... time to learn about its electrical and magnetic properties ...
(Date:12/4/2009)... CORALVILLE, Iowa, Dec. 4 Vivakor, Inc. (OTC Bulletin ... on December 1, 2009 will receive the dividend of ... previously approved by Vivakor,s Board of Directors. HealthAmerica ... approximately 84% of the outstanding common shares on the ...
(Date:12/4/2009)... Centre for Advanced Micro Nano Technology Products (ACAMP) ... , EDMONTON, Dec. 4 /PRNewswire/ - Today ACAMP ... technologies like nanotechnology, biomaterials and microfluidics can play ... healthcare products that help promote health and improve ...
Breaking Biology Technology:RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 2RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 4RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 5RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 6NIST researchers put a new spin on atomic musical chairs 2Vivakor Confirms Record Date of Stock Dividend 2Vivakor Confirms Record Date of Stock Dividend 3Alberta companies delivering new products to the health & medical marketplace 2... OXFORD, England, February 28, Evotec AG (Frankfurt Stock ... Phase II study for EVT 302 in smoking,cessation, ... oxidase,B (MAO-B)., This double-blind, three-way cross-over study ... on craving and withdrawal symptoms,after short-term deprivation of ...
... 28, 2008, New England Journal of Medicine, led by ... of the University of Massachusetts Medical School (UMMS), indicates ... may be the first demonstration of a link between ... of Massachusetts has offered universal newborn screening to detect ...
... LIONVILLE, Pa., Feb. 27 West Pharmaceutical,Services, Inc. (NYSE: ... a second quarter 2008 cash dividend of $0.14 per share. ... of record on April 23,2008., The Company also announced ... an average price of $40.23 per share since the,announcement of ...
Other Biology Technology:Evotec Starts Phase II in Smoking Cessation with EVT 302 2Data show a decline in cystic fibrosis since introduction of prenatal carrier screening 2(Date:12/5/2009)... could become the source of more of humanity,s food ... aquaculture, according to a study published in the December ... world,s population continues to grow, lack of fresh water ... be able to meet food demand, according to Carlos ... Spain, and his seven coauthors. Freshwater aquaculture, which is ...
(Date:12/5/2009)... the exhaustive research into venom produced by snakes and ... of a mystery. Now, a study of 158 catfish ... Evolutionary Biology , has catalogued the presence of venom ... Jeremy Wright, from the University of Michigan, USA, carried ... toxicological techniques to elucidate the diversity and distribution of ...
(Date:12/4/2009)... is a battle zone. Cells constantly compete with one another ... cells win this competition is well known to be the ... for space and survival is not as clear. A study ... Science by Johns Hopkins researchers describes how stem ...
Breaking Biology News(10 mins):Stem cells battle for space 2Accera Inc to Present at UBS Global Life Sciences Conference 57667 1Accera Inc to Present at UBS Global Life Sciences Conference 57667 2Gene Mutation Linked to Fever Induced Seizures 57663 1Gene Mutation Linked to Fever Induced Seizures 57663 2Public Option Still Viable As House Set to Pass It Not Fading Says Robert Weiner Former House Aging Committee Director 57660 1Public Option Still Viable As House Set to Pass It Not Fading Says Robert Weiner Former House Aging Committee Director 57660 2...
Anti-ZFP-38/RU49 Family: Zinc Finger Peptide Sequence: SVKVEDKDFPSTCSKK...
TRIzol Reagents are ready-to-use monophasic solutions of phenol and guanidine isothiocyanate suitable for isolating total RNA DNA and proteins (16)....
Antibodies were affinity purified using epitopes specific to UBAP2L/NICE4 immobilized on solid support....
Biology Products: